Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Minerva Neurosciences, Inc. Director's Dealing 2017

Dec 15, 2017

35086_dirs_2017-12-15_a269eccb-b12c-4fd2-b54e-71d8b1221af9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2017-12-13

Reporting Person: Race Geoff (EVP, CFO & CBO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-12-14 Common Stock M 12500 Acquired 197698 Direct
2017-12-14 Common Stock S 5829 $5.79 Disposed 191869 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-12-13 Employee Stock Option (Right to Buy) $6.10 A 200000 Acquired 2027-12-13 Common Stock (200000) Direct
2017-12-14 Restricted Stock Unit $ M 12500 Disposed Common Stock (12500) Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock

F2: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock
in connection with the settlement of the vested portion of RSUs pursuant to the terms of that certain RSU Agreement between the Reporting Person and the Issuer, as reflected in this Form 4.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.75 to $5.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.

F4: This option vests as to 25% of the shares on December 13, 2018 and then in quarterly installments over 3 years thereafter.

F5: Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date.